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ScienceDirectThe sensitivity of biological materials to shear stress conditions
encountered during large-scale bioprocessing makes
successful scale up from the bench challenging. Ultra scale-
down technologies seek to use just millilitre quantities to
enhance our understanding of the impact of the process
environment as a basis for process optimisation. They can help
speed translation of new biological discoveries to market and
reduce risks encountered in scale up. They are important both
as process discovery tools and as preparative tools to yield
material for study of subsequent stages. In this review the focus
is on the early recovery stages post fermentation or cell culture
and in particular the use of continuous-flow and dead-end
centrifugation integrated with preparative stages (e.g.
flocculation) and subsequent depth filtration. Examples range
from therapeutic antibodies, to rationally engineered (synthetic
biology) host strains, to stem cells for therapy.
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Bench-scale technologies for application of
process-scale shear stress
All stages of an industrial sequence for the preparation of
a biological therapeutic involve exposure of the material
to various forms of stress, that is, mechanical or different
types of hydrodynamic stress. In this review we are
concerned with hydrodynamic stress as commonly occurs
during flow within and through process equipment. In
some cases the stress applied is similar at bench and
industrial scale but often the stress applied at full scale
far exceeds that at bench scale. Notable examples include
pump transfers (e.g. [1]), flow through valves, feed withinCurrent Opinion in Chemical Engineering 2016, 14:150–157 continuous-flow high speed centrifuges [2] and the dis-
charge of supernatant and sediment phases [3]. There are
also examples of high stress occurring at bench scale not
reproduced at full scale, for example, flow through pip-
ettes [4], mixing using surface mounted (grinding) mag-
netic stirrers.
A key objective of ultra scale-down technologies
(Figure 1) is to determine if the biological material is
susceptible to applied process shear stress, and if so to
quantify the effect of shear stress on the material and on
the performance of subsequent unit operations, for ex-
ample, filtration or chromatography. Two geometries are
commonly used at bench scale to expose process material
to hydrodynamic shear stress:
(a) Capillary flow — here, exposure to stress occurs on
entry to and exit from the capillary, flow through the
capillary and impact of the discharged jet on the
collection surface. The flow in the capillary pro-
gresses from undeveloped to laminar rather than
turbulent flow as opposed to turbulent flow in many
large-scale applications.
(b) Rotating disc flow — here, flow occurs over the
rotating disc surface housed within a chamber
(Figure 2). The greatest stress occurs at the disc
tip with both rotational flow and radial flow impacting
on the chamber surface. The flow is generally highly
turbulent but heterogeneous in nature.
Examples of materials studied include for capillary flow:
mammalian cells (e.g. [5,6,7]) and cells for therapy [8,9];
and for rotational flow: precipitates (e.g. [10]), mammalian
cells (e.g. [11]), cells for therapy (e.g. [12]), adjuvants
(e.g. [13]), flocs (e.g. [14]), phages (e.g. [15]) and anti-
bodies (e.g. [16,17]).
Bench-scale technologies for centrifuge ultra-
scale down
All bioprocess stages pose particular challenges in achiev-
ing successful scale-down in a conventional sense, that is,
maintaining geometric similarity. For example, for
packed bed chromatography the need to maintain the
same bed height and superficial velocity means that scale
down is ultimately limited by the column diameter be-
yond which it is necessary to reduce column height and
hence residence time for binding or superficial flow
velocity. Similarly for membrane separation when it iswww.sciencedirect.com
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The role of ultra scale-down in speeding bioprocess development.
Process characterisation is needed to evaluate manufacturability of a
new product or to evaluate the process impact of introducing a new
host, that is, through screening or rational engineering (synthetic
biology) approaches. (1) Specification of whole bioprocess from
fermentation/cell culture to formulation. (2) Identification and
characterisation of critical regimes, for example, of high shear stress,
long hold times, hostile interfaces, etc. (3) Use of ultra scale-down
methods to prepare material and for testing of sensitivity to critical
regimes and impact on rest of process. (4) Use of new insight to
respecify process sequence, for example, remove regimes resulting in
product damage. (5) With increased confidence in ability of ultra scale-
down methods to predict pilot and full-scale operations focus on
process refinement rather than process reinvention.no longer possible to maintain the same membrane length
and hence profile of transmembrane pressure drops.
However, the translation from small (ca 10s mL) bench
scale (where scale down rules cannot be followed) to pilot
scale is eased by the availability of large (ca 100s mL)
capacity bench-scale devices which can keep to scale
down rules [18–20]. Such devices are not available for
pilot-scale continuous-flow centrifugation and, here, scale
down requires a major change in geometry for operation at
scales of less than 1000s mL.
The classical approach for scale down of full-scale (FS)
centrifugation is based on the definition of an equivalent
area of a gravity settling pond, SFS. Here, the geometry
and rotational speed of a centrifuge is used to compute
the settling of particles during suspension flow throughwww.sciencedirect.com the centrifuge. A characteristic clarification performance
is used to define SFS for the centrifuge. This theoretical
analysis needs to be accompanied by an experimental
study to help characterise non-idealities in flow, for
example, due to turbulence or due to particle resuspen-
sion. Within this review this calibration factor is incorpo-
rated within the value of SFS. On this basis, the
centrifuge performance is simply characterised by the
ratio of flow rate, QFS, to settling area. While this does
not allow scaling based on dewatering or on sediment
capacity, it does provide a useful basis for clarification, the
main function of many centrifugation stages during re-
covery.
The translation from a full-scale continuous-flow centri-
fuge to a bench-scale batch test tube centrifuge is a
considerable challenge. The equivalent settling area,
SUSD, of a test tube housed in a centrifuge head is defined
in terms of the inner and outer radii of the suspension (R1
and R2) and the rotational speed, N, and using the same
separating criteria as for the full-scale centrifuge. The
suspension volume, VUSD, and the spin time, tUSD, give
the equivalent flow rate such that we have the following
expressions:
X
USD
¼ VUSDð2pNÞ
2
6glnð2R2=ðR2 þ R1ÞÞ
S ¼ f VUSD
tUSDSUSD
 
¼ f QFS
SFS
 
where S is solids remaining in supernatant. Typical values
of (VUSD/tUSDSUSD) range from 1  109 m3 m2 s1 to
mimic a high speed centrifuge operating at low flow rate
to 100  109 m3 m2 s1 to mimic a high speed centri-
fuge operating at high flow rate, the upper limit to recover
low density difference 0.1–100 mm sized biological par-
ticles. Typical values of SUSD are 0.01–0.5 m
2, typical
values of SFS for pilot-scale centrifuges are 500–5000 m
2.
Careful attention is needed to make sure the acceleration
and deceleration phases of bench-scale centrifuge opera-
tion do not unduly affect the extent of clarification (see
[21] for correction factors) and that supernatant withdrawal
does not lead to resuspension of the often loosely com-
pacted sediment [22]. However, the greatest challenge is
the nature of the feed to a continuous centrifuge and the
impact of process shear stress. Incoming material is subject
to considerable acceleration forces and estimated maxi-
mum energy dissipation rates range from 45 W/mL to
530 W/mL [2,14]. These are considerably higher stresses
than those which occur in preceding stages such as reactors
for cell growth, or for cell lysate, precipitate, floc or crystal
preparation and are probably of similar orders of magnitude
as occur in devices used for mechanical cell disruption
(high pressure or bead mill homogenisers). The design ofCurrent Opinion in Chemical Engineering 2016, 14:150–157
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An ultra representation of energy dissipation rate a ratescale-down approach to investigating process material shear sensitivity at the laboratory
scale. This is achieved using a rotating disc device (kompAsTM) which produces defined levels of hydrodynamic shear stress (energy dissipation
rate: 1–1000 W mL1), comparable to those found in industrial equipment such as centrifuges or pumps. The total volume of process material
required (20 mL) is sufficient for further studies such as USD centrifugation and/or USD filtration as well as analytical measurements of the product
and impurities. Note that the colour scale is a logarithmic representation of energy dissipation rate.the feed zone to the centrifuge determines the level of
shear stress, for example, hermetic or hydrohermetic
designs to eliminate or minimise the air core in the entry
feed zone allow more gentle acceleration of the feed
suspension. It is important to determine if this is a critical
design feature for the material being processed as results of
primary recovery operation could vary [10,11].
Other sources of stress can include the discharge of the
supernatant that can be via a centripetal pump into a pipe
or by high velocity flow over a weir into a capture vessel.
The discharge of the solids can either be via intermittent
high velocity nozzle discharge [3] or continuous nozzle
discharge at a velocity determined by the centrifuge
design, for example, discharge at the outer bowl [23] or
via the bowl axis with a relationship determined by the
extent of dewatering achieved [24,25]. The resuspension
of high viscosity sediment can also be a high stress process
especially via manual pipetting at bench scale [4].
The relative importance of these various stress effects is
determined by the material being processed and the
product form/location, for example, supernatant or sedi-
ment and the place of the centrifuge operation in the
bioprocess sequence. At present, in the absence of a
generic design procedure, this is best studied via particu-
lar examples of process sequences.Current Opinion in Chemical Engineering 2016, 14:150–157 Ultra scale-down studies of bioprocess
sequences
A general overview of scale down of biochemical engi-
neering options has been provided elsewhere [26]; the
focus here is on use of ultra scale-down and the enhanced
bioprocess understanding which is gained in particular
downstream processing sequences in the early recovery
stages.
Interaction of homogenisation and centrifugation
One route for the recovery of intracellular products is via
high pressure homogenisation followed by centrifugal
removal of the cell debris. Adaptive focused acoustics
has been used to mimic the high pressure homogenisation
of recombinant Escherichia coli for the release of an anti-
body fragment and the formation of cell debris of specific
size distribution as well as the release and disruption of
nucleic acids [27]. A homogeniser operating on a recycle
loop followed by a disc stack centrifuge for debris removal
was successfully mimicked by a combination of bench-
scale adaptive focused acoustics and ultra scale-down
centrifugation (as described above) to demonstrate how
challenging is the removal of micronized cell debris
formed from the need for multiple recycles to achieve
near complete protein product release [28]. The impact
has also been demonstrated of cell wall weakening during
extended fermentation leading to reduced centrifugewww.sciencedirect.com
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gy approaches have been studied using ultra scale-down
methods to rationally engineer cells with improved char-
acteristics for bioprocessing. In one example, the use of a
strain engineered with an inducible nuclease has been
shown using to enhance the processability of recombinant
E. coli homogenates [30]. Similarly, ultra scale-down
methods predicted the effect of the micellar state of
lipids and their removal to avoid fouling for hydrophobic
resins [31].
Interaction of flocculation, centrifugation and depth
filtration
Flocculation in this review relates to use of polymeric
reagents (e.g. polyethyleneimine (PEI) or polydiallyldi-
methylammonium chloride (PDADMAC)) for the selec-
tive precipitation (e.g. of nucleic acids) and aggregation
(e.g. of colloidal proteins, lipopolysaccharides, colloidal
proteins) of biological contaminants (e.g. [14,32,33–35]).
It is used in a process sequence to offer a rapid clean-up of
a complex bioprocess stream before progression to a
sensitive chromatographic or selective adsorption separa-
tion stage. The ultra scale-down of floc preparation fol-
lows the same rules as for a precipitate (see below) with
regards to mixing conditions and times. The ability to
work at small scale allows study of the effect of floc agent
properties (e.g. molecular weight, concentration, degreeFigure 3
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(a) Flocculation is used to process an autolysised E. coli cell broth removin
contaminants, for example, nucleic acids, while the exposure (for 20 s) to h
reappearance of sub-micron particles leading to ultra scale-down prediction
that are verified at pilot scale [37]. (b) The fine particles formed as a result 
be difficult to remove by centrifugation and subsequent filtration [11].
www.sciencedirect.com of molecular unravelling etc.), as well as sensitivity to
mixing conditions [36]. Key findings include the use of
flocculating agents to remove the presence of small (mi-
cron sized) particles to form large flocs that are sensitive to
the effects of shear stress. However, the micron sized
particles do not reappear and, because the particles re-
main well above the critical size for centrifugal removal,
high levels of clarification are achieved (Figure 3a). For
example, in one study combining ultra scale-down floc-
culation, shear stress and centrifugation the use of floc-
culation was predicted to reduce contaminant carry-over
by >50-fold [14] with greater ease of depth filtration of
the subsequent supernatant [14,37]. This was then veri-
fied at pilot scale [14,32,37]. Verification at pilot scale of
ultra scale-down predictions is critical to provide confi-
dence for design predictions and has been achieved for
other flocculated systems (e.g. [38]).
Interaction of precipitation and centrifugation
In the context of this review, precipitation is generally
achieved via a change in the process environment, for
example, pH, ionic strength, dielectric constant etc. or
combinations thereof. Precipitation continues to be ex-
plored to provide novel solutions to bioprocessing (e.g.
[39–41]). The product or the contaminants may be sub-
ject to precipitation and then generally removal/recovery
by centrifugation [21] or possibly filtration [20] especially50 0 10 20 30 40 50
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le size (μm)
45 W/mL
/mL 530 W/mL
530 W/mL
Current Opinion in Chemical Engineering
g all sub-micron cell debris and also precipitating soluble
igh shear stress decreases the average particle size, there is no
s of high levels of clarification in continuous flow centrifugation [14]
of the application of shear stress (20 s) on mammalian cell broth will
Current Opinion in Chemical Engineering 2016, 14:150–157
154 Biotechnology and bioprocess engineeringif the product remains in the soluble phase. The control of
the properties of the precipitate is achieved by the choice
of reactor conditions of the mean velocity gradient
(G = (P/Vm)0.5) where P is power dissipated in a volume,
V, with suspension viscosity, m, and residence time, t. The
precipitate particle size is generally inversely proportional
to G. The dimensionless Camp number (Ca = Gt) deter-
mines the strength of the precipitate with maximum
resistance to disruption to shear stress being observed
for Ca > 105 [42]. However, even after such ageing the
precipitate is still strongly susceptible to shear stress
induced break up, for example, in pumps or in centrifuge
feed zones. Examples of successful USD prediction of
precipitation and precipitate recovery by centrifugation
have been achieved, for example, salt precipitation of
microbial proteins or ethanol precipitation of blood plas-
ma proteins [10].
Interaction of suspension cell culture, harvest,
centrifugation and filtration
The production of monoclonal antibodies and other pro-
tein products via mammalian cell culture involves firstly a
sequence of solid-liquid separation stages to prepare a
clarified broth suitable for chromatographic or adsorption
based separation. The cells are cultured in a relatively low
shear stress environment and high levels of shear stress
may lead to considerable attrition (Figure 3b) and release
of intracellular components. The impact of such disrup-
tion on the centrifugal clarification of cell broth has been
studied with the use of a high stress feed zone predicted to
lead to over 10-fold increase in solids carryover compared
with no shear stress (Figure 4). The use of a low stress feedFigure 4
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Current Opinion in Chemical Engineering 2016, 14:150–157 zone reduces such carryover very significantly
[11,22,43,44] and using ultra scale-down filtration tools
[45–47] is shown to enhance the performance of subse-
quent filtrations stages [48]. The correct back pressuring of
a centrifuge to maintain a low shear stress (hydrohermetic)
feed zone may be defined as a Critical Process Parameter
when the validation of such a bioprocess is addressed. The
impact of such shear stress on the protein product might
need to be considered, for example, for a monoclonal
antibody no impact on glycosylation pattern was observed
but the presence of half antibodies increased [49] while for
a fusion protein a large impact on extent of glycosylation
was observed [50]. Improvements in mammalian cell
biology have been predicted to be best realised by use
of low shear stress processing options [51]. The effect of
surface interactions under shear stress has been reported
for antibodies leading to loss of functionality in solutions
without the appropriate protective agents [16,17,52].
Interaction of surface-attached cell culture,
centrifugation and resuspension
The preparation of cells for therapy is one of the most
challenging areas in terms of understanding the impact of
the processing environment on the product [53]. For
allogeneic therapies, such as multi-potent adult stem cells
(MPACs), the scale of production is often near the limit of
analytical techniques so the challenge is to understand
the effect of the processing environment. For autologous
therapies, such as induced pluripotent stem cells (iPS
cells) or T-cells, there is also the challenge of scale-down.
As might be expected different cell lines respond very
differently to the application of process stress [12,54]high shear feed
Low shear feed
9 20 30 60
Pilot scale
QFS/ ΣFS (m3 m–2 s–1) ×10–9
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ation was used to predict the carryover of solids during clarification of
 in solids carryover was verified at pilot scale (SFS = 2500 m2,
entrifuge. The use of no shear bench-scale centrifugation significantly
 [11]. Solid lines are fits by regression of the ultra scale-down data,
ar ultra scale-down data fits are transposed to show match with pilot-
www.sciencedirect.com
Genetically-encoded biosensors for improve biosynthesis Rayat et al. 155and for a particular cell line the cell passage number,
generation number and method of growth all affect the
response to shear stress [55]. Capillary based studies have
been used to reduce the number of cells required for
process characterisation [9]. As predicted [7,56,57] the
main reason for damage is due to extensional flow at
the capillary entrance but careful computational analysis
of the particle and fluid dynamics is needed to identify
regimes of exposure of cells to stress. The translation of
such results has led to an understanding of the reasons for
cell loss during operation of scale-down mimics of dead-
end centrifugation where the combination of pipette flow
velocities and sediment rheology [58] led to stresses
exceeding the predicted process stress for damage and
solutions to reduce such stress [4]. Capillary flow has been
used to gain further understanding of the reasons for other
causes of cell damage [8,59]. Similar ultra scale-down tools
are needed to explore new options for cell recovery, for
example, cross flow filtration or expanded bed centrifuga-
tion [4] and washing and administration.
Conclusions
An increasing number of stages in a bioprocess are becom-
ing accessible to investigation using ultra scale-down
methods, including continuous operations. This review
has focused on one of the major challenges for scale down,
that is, centrifugation, especially as a key stage between
cell culture/fermentation and chromatographic purifica-
tion. Examples are provided of the successful application
of ultra scale-down methods for a range of bioprocess
sequences.
The ability to complete ultra scale-down studies of whole
bioprocess sequences will allow low cost development of a
full-scale process while assurance is awaited of the clinical
safety and efficacy of the candidate therapy. Then it will
be possible to move at speed to large-scale manufacture.
As more complex therapies become the deliverable of
value, the use of ultra scale-down to help enhance process
development at low cost is likely to become increasingly
important. Ultra scale-down methods also provide a quan-
titative and predictive methodology by which to assess
the benefits of host cell engineering (synthetic biology)
on whole bioprocess performance.
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